Stronger Together: Neurolex develops a “vocal biomarker” to rapidly screen for COVID-19
CEO Jim Schwoebel founded Neurolex after his brother experienced a psychotic episode, and he noticed that his brother’s voice changed. The Boston-based company has developed “vocal…